Fibrinogen and fibrin degradation products in hemolytic transfusion reactions.
D001778:Blood Coagulation Disorders / Q000209:etiology*; D001780:Blood Coagulation Tests; D001787:Blood Group Incompatibility; D002585:Cesarean Section; D003093:Colitis, Ulcerative / Q000601:surgery; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D005342:Fibrinolysis; D006461:Hemolysis; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000209:etiology*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications; D011247:Pregnancy; D065227:Transfusion Reaction
D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin